Krishna Theja Reddy, MD
Cardiovascular Disease · West Des Moines, IANPI 1962964718
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 42.9% of the total. Reporting peaked in 2024 at $2,785 and has fallen 54.6% since, to $1,264 in 2025.
Across 61 payments — averaging $81.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Biotronik Inc.$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$382
- Shockwave Medical, Inc$343
- AstraZeneca$140
- Medtronic$92
- plus $187 from 7 others
What the payments were for
- Travel & lodging$2,07942%
- Food & beverage$2,31647%
- Education$55711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 19 | $2,127 |
| Biotronik Inc. | 15 | $1,682 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $382 |
| Shockwave Medical, Inc | 2 | $343 |
| AstraZeneca | 2 | $140 |
| Medtronic | 3 | $92 |
| Amgen | 2 | $43 |
| Terumo Medical Corporation | 1 | $35 |
| Boehringer Ingelheim | 1 | $34 |
| Cardiva Medical, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $22 |
| Novartis | 1 | $15 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$984
- PAMIRA$607
- Solia$607
- AMVIA EDGE$607
- Selectra$607
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$343
- PRESSUREWIRE$266
- ENSITE$237
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$135
- CARDIOMEMS$132
- ANDEXXA$125
How this compares
$4,953 in reported general payments places this provider in the 80th percentile of 142 cardiovascular disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 19 | $97 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in West Des Moines
- Troy HounshellWest Des Moines$164K
- Enrico MartinWest Des Moines$113K
- Suzanne FeigofskyWest Des Moines$59K
- Robert PaulWest Des Moines$9K
- Lucas GrobenWest Des Moines$6K
- Randolph RoughWest Des Moines$3K
- Paul WesleyWest Des Moines$2K
- Brian OlshanskyIowa City$219K
- Gursukhman Deep SidhuDavenport$60K
- Tyler RasmussenCedar Rapids$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.